Skip Navigation


Rheumatology Advance Access originally published online on June 8, 2004
Rheumatology 2004 43(8):980-985; doi:10.1093/rheumatology/keh240
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
43/8/980    most recent
keh240v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Katayama, R.
Right arrow Articles by Kimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katayama, R.
Right arrow Articles by Kimura, T.
Related Collections
Right arrow Osteoarthritis and Cartilage
Right arrow Experimental Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 8 © British Society for Rheumatology 2004; all rights reserved

Paper

Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow

R. Katayama, S. Wakitani1, N. Tsumaki2, Y. Morita, I. Matsushita, R. Gejo and T. Kimura

Department of Orthopaedic Surgery, Toyama Medical and Pharmaceutical University, Toyama, 1 Department of Orthopaedic Surgery, Shinsyu University, Nagano and 2 Department of Orthopaedic Surgery, Faculty of Medicine, Osaka University, Osaka, Japan.

Correspondence to: T. Kimura or (reprints) R. Katayama, Department of Orthopaedic Surgery, Toyama Medical and Pharmaceutical University, Toyama, Japan. E-mail (Kimura): tkimura{at}ms.toyama-mpu.ac.jp; (Katayama) riek{at}ms.toyama-mpu.ac.jp

Objective. Cartilage-derived morphogenetic protein 1 (CDMP1), which is a member of the transforming growth factor-ß superfamily, is an essential molecule for the aggregation of mesenchymal cells and acceleration of chondrocyte differentiation. In this study, we investigated whether CDMP1-transfected autologous bone marrow-derived mesenchymal cells (BMMCs) enhance in vivo cartilage repair in a rabbit model.

Methods. BMMCs, which had a fibroblastic morphology and pluripotency for differentiation, were isolated from bone marrow of the tibia of rabbits, grown in monolayer culture, and transfected with the CDMP1 gene or a control gene (GFP) by the lipofection method. The autologous cells were then implanted into full-thickness articular cartilage defects in the knee joints of each rabbit.

Results. During in vivo repair of full-thickness articular cartilage defects, cartilage regeneration was enhanced by the implantation of CDMP1-transfected autologous BMMCs. The defects were filled by hyaline cartilage and the deeper zone showed remodelling to subchondral bone over time. The repair and reconstitution of zones of hyaline articular cartilage was superior to simple BMMC implantation. The histological score of the CDMP1-transfected BMMC group was significantly better than those of the control BMMC group and the empty control group.

Conclusion. Modulation of BMMCs by factors such as CDMP1 allows enhanced repair and remodelling compatible with hyaline articular cartilage.

KEY WORDS: Cartilage repair, Mesenchymal cell, Chondrogenic differentiation, CDMP1


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.